Athlone Pharmaceuticals.

Your partner of choice, where
excellence matters.
Exterior of Athlone Pharmaceuticals building featuring the company logo and signage.

ABOUT US

Welcome to Athlone Pharmaceuticals.

Athlone Pharmaceuticals is part of the Kent-Athlone Pharma Group, based in Dublin. This office also serves as the Group’s European HQ.
Since the business was launched in late 2020, we have gone from strength to strength, supplying all Hospitals and Retail Pharmacies nationwide in Ireland.

We are one of the fastest growing specialty pharmaceutical companies in Ireland with a diverse product portfolio. Our focus is on Anti-infectives and Oncology Medicines, whilst the broader portfolio contains other products including Anaesthetics and Vitamins.

OUR COMPANIES

The Kent-Athlone Pharma Group of Companies

As one of the fastest growing specialty pharmaceutical companies in the Republic of Ireland, Athlone Pharmaceuticals supplies a comprehensive range of value-added medicines to hospitals and retail pharmacies nationwide.

Established in 1986, Kent Pharma is recognised as a leading sales and marketing distributor of value-added medicines. We supply the NHS and retail pharmacy via wholesalers in the UK, as well as international markets.

MEET THE TEAM

Our experienced team

Barry Doyle, Country Manager at Athlone Pharmaceuticals, professional headshot.

Barry Doyle

Country Manager

Conor Keane, Business Development at Athlone Pharmaceuticals, professional headshot.

Conor Keane

Business Development

Mruga Panvalkar, Marketing Executive at Athlone Pharmaceuticals, professional headshot.

Mruga Panvalkar

Marketing Executive

Richard Doherty, Key Account Manager – Retail at Athlone Pharmaceuticals, professional headshot.

Richard Doherty

Key Account Manager – Retail

Keith Sheridan, Hospital Account Manager at Athlone Pharmaceuticals, professional headshot.

Keith Sheridan

Hospital Account Manager

OUR HISTORY

A Heritage of Innovation and Growth

2020

Athlone Pharmaceuticals distribution business launched in Ireland

2022

Kent Pharma acquires Dalkeith Group of Companies

2024

Defined Re-focused 5
Year Strategy for
Growth

2025

Kent-Athlone Pharma Group divests Athlone Laboratories

Today

Continuing to
introduce more
products
Map showing Kent-Athlone Pharma Group locations across Ireland and the UK, including headquarters, manufacturing facilities and export operations.

Our Presence

EU Headquarters and Athlone Pharmaceuticals:

Dublin, Ireland

Group Headquarters and UK Affiliate:

Ashford, UK

Over-Labelling Production & Distribution Centre:

Measham, UK

Formulation Development Laboratory:

Huddersfield, UK

Export Products

Both from the UK and Ireland to Europe and beyond.

OUR STRATEGY

Building a European Specialty Pharmaceutical Company,
to deliver rapid, profitable growth

AMR Industry Alliance logo representing global collaboration against antimicrobial resistance.
Medicines for Ireland (MFI) logo with the tagline Medicines for All, representing Ireland's pharmaceutical industry.

Looking for Pharmaceutical Solutions?

Whether you’re interested in our expanding product range or would like to
discuss working with Athlone Pharmaceuticals, we’d love to hear from you.
Barry Doyle, Country Manager at Athlone Pharmaceuticals, professional headshot.

Barry Doyle

Country Manager

Barry Doyle is Country Manager of Athlone Pharmaceuticals and has over 16 years’ experience across the pharmaceutical and healthcare sectors, with particular expertise in generic, OTC and prescription medicines. He is responsible for the company’s strategic growth, portfolio development, licensing activities and commercial operations in Ireland.

Barry has held senior commercial roles with Chanelle Pharma, Actavis and Allphar Uniphar, following earlier experience in the FMCG sector with Glanbia and Kerry Group. His expertise spans business development, sales leadership and supply-chain strategy, supported by a strong understanding of regulatory engagement, pricing and reimbursement, and pharmacy-channel operations across both human and veterinary medicines.

Barry also serves on the boards of the Irish Medicines Verification Organisation (IMVO) and Medicines for Ireland, contributing his industry experience to the continued development of Ireland’s medicines sector.

He holds a Master’s degree in Business (Leadership and Management Practice) from UCD Michael Smurfit Graduate Business School and is a graduate of the Kerry Group Graduate Programme.

Conor Keane

Business Development

Conor Keane brings over 11 years of experience in the pharmaceutical industry, with expertise across commercial operations, business development, reimbursement, supply chain and market access. Having previously worked with United Drug, Conor joined Athlone Pharmaceuticals at the outset and has played an integral role in the company’s growth and development from the beginning.

During his time with the business, he has supported the successful introduction and launch of multiple key products across the portfolio, working closely with manufacturers, suppliers, wholesalers, healthcare providers and internal teams to bring opportunities from initial concept through to commercialisation.

His broad understanding of the Irish pharmaceutical market provides valuable insight across reimbursement pathways, pricing, tenders, forecasting, product launches, commercial strategy and operational processes. He also plays a key role in identifying and evaluating new business opportunities, developing business cases and supporting the ongoing growth of the company’s product portfolio.

With a strong combination of commercial, operational and industry knowledge, Conor contributes across multiple areas of the business and supports the company’s continued growth in the Irish pharmaceutical market.

Mruga Panvalkar

Marketing Executive

Mruga Panvalkar is a Marketing Executive at Athlone Pharmaceuticals with over seven years of experience in the pharmaceutical and healthcare industry. As a qualified pharmacist, she combines scientific knowledge with expertise in pharmaceutical marketing, including brand development, product launches, market research and digital marketing.

Over the course of her career, Mruga has worked with several pharmaceutical and healthcare companies, including West Pharmaceutical Services, a global company specialising in components and delivery systems for injectable medicines. These roles have given her experience across pharmaceutical marketing, healthcare products and the wider industry.

She holds two master’s degrees, including an MSc in Marketing from Dublin Business School, Ireland. Combining pharmaceutical knowledge, marketing expertise and industry experience, she supports the commercial development of Athlone Pharmaceuticals’ growing product portfolio.

Richard Doherty, Key Account Manager – Retail at Athlone Pharmaceuticals, professional headshot.

Richard Doherty

Key Account Manager – Retail

Richard Doherty brings over 25 years of commercial experience within Branded/Generic pharmaceuticals and O.T.C medicines. He has a wealth of experience across the retail Irish pharmacy market, having successfully led numerous key product launches across a broad range of therapeutic areas. Richard is highly respected in the Irish Pharmacy sector with a strong stakeholder network across the industry.

Keith Sheridan, Hospital Account Manager at Athlone Pharmaceuticals, professional headshot.

Keith Sheridan

Hospital Account Manager

Keith Sheridan is the Hospital Account Manager at Athlone Pharmaceuticals, bringing over 20 years of experience in the pharmaceutical industry. He has a proven track record of building strong customer relationships and developing strategic partnerships across hospital, primary care, pharmaceutical wholesale, and community pharmacy sectors.

Prior to joining Athlone Pharmaceuticals, Keith held a number of commercial and account management roles with leading healthcare companies, including Novartis, GSK, and Fresenius Kabi. Throughout his career, he has consistently delivered business growth by providing customer-focused solutions that support both clinical and commercial objectives.